http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-080884-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 |
| filingDate | 2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-080884-A1 |
| titleOfInvention | INSULIN-SIRNA CONJUGATES |
| abstract | It refers generally to therapeutic compounds and useful methods for treating diseases in humans. More specifically, it refers to methods and reagents useful for treating humans suffering from metabolic diseases. More specifically, it refers to covalent insulin conjugates and analogs with nucleic acid derivatives that are capable of modulating gene expression. In addition, this refers to the use of said conjugated insulins for the treatment of metabolic diseases, including diabetes mellitus. Claim 1: The chimeric compound comprising an insulin and its siRNA. |
| priorityDate | 2010-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.